Quidel secures EUA for rapid antigen test

By LabPulse.com staff writers

June 15, 2021 -- Quidel has garnered an emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its Sofia Q rapid antigen test, the latest addition to the company's line of fluorescent immunoassay analyzers (FIA).

Sofia Q features a miniaturized design that can provide the same level of accuracy on Sofia SARS antigen FIA tests as Quidel's Sofia and Sofia 2 offerings, according to the vendor. The device can be paired with the Sofia Q mobile app to guide users through the workflow and interpret test results using an artificial intelligence (AI) algorithm. Results from Sofia Q are available in 15 minutes, Quidel said.

The firm will initially make Sofia Q available only for the professional and point-of-care market segments but plans in the future to also offer the system for telemedicine and home use.

Quidel secures Health Canada approval for Sofia SARS-CoV-2 test
Health Canada has approved Quidel's Sofia antigen test for the detection of coronavirus infection in both symptomatic and asymptomatic people.
Boom in COVID testing drives Quidel's Q1 financials
Quidel on April 22 announced preliminary numbers for the first quarter of 2021 that saw revenue from the company's line of COVID-19 tests boom to $280 million...
Quidel nabs EUA from FDA for SARS-CoV-2 antigen test
Quidel has received emergency use authorization (EUA) from the U.S. Food and Drug Administration (FDA) for its QuickVue point-of-care assay that detects...
Quidel gets EUA for combo flu, COVID-19 test
Quidel has received a U.S. Food and Drug Administration emergency use authorization (EUA) for a rapid diagnostic that can simultaneously identify influenza...
Quidel closes Vermont investigation of Sofia test
Quidel has completed its investigation of false-positive results for COVID-19 at a testing location in Vermont. The company said it found no testing site-...

Copyright © 2021 LabPulse.com

Last Updated ls 6/15/2021 4:33:17 PM



Subscribe Today
Do you want to be a Microbiology Insider?

When LabPulse gets hot new information, our Insiders are the first to find out. Stay current in today's competitive market by receiving our exclusive free email updates.

Yes, Keep Me Current